Unacceptably high rates of adverse outcomes persist for childbearing women and infants, including maternal and newborn mortality, stillbirth, and short-term and long-term morbidity. 1 In light of the challenges to achieve the UN Sustainable Development Goals, it is timely to reconsider priorities for research in maternal and newborn health. Are we asking the right questions? 2 Recent evidence indicates the importance of seeking knowledge beyond the treatment of complications, to inform better ways of providing sustainable, high quality care, including preventing problems before they occur. 3 The 2014 publication of The Lancet's Series on Midwifery presented a unique opportunity to generate future areas of inquiry by drawing on the most extensive examination to date of evidence on the care that all women and newborn infants need across the continuum from pre-pregnancy, birth, post partum, and the early weeks of life. [4] [5] [6] The Series summarised the evidence base for quality maternal and newborn care in a new framework that focuses on the needs of women, infants, and families and diff erentiates between what care is provided, how it is provided, and by whom. 4 These are concepts that are often confused or ignored in existing studies. Midwifery was identifi ed as a cost-eff ective and fundamentally important element of quality care, with the potential to improve over 50 diff erent maternal and newborn outcomes including mortality and morbidity. However, there are substantive barriers to proper implementation and integration of midwifery into health systems. 1 We adapted the Child Health and Nutrition Research Initiative (CHNRI) methodology to score competing future research topics on quality maternal and newborn care and the contribution of midwifery to that care. 7 This method has been used to set health research priorities for infant and childhood conditions, 8, 9 reduction of maternal and perinatal mortality, 2 and preterm birth and stillbirths. 10 A 30 research topics based on an analysis of gaps in the evidence presented in the 2014 Lancet Series on Midwifery. Stakeholders were asked to consider the potential research topics in terms of their relevance, signifi cance, and potential future implement ation based on fi ve criteria: answerability, community involvement, sustainability, equity, and maximal impact. 7 The 30 research topics and scoring criteria were distributed in English, French, and Spanish online surveys to 1191 stakeholders, including constituents of the global Partnership for Maternal, Newborn, and Child Health (PMNCH) and representatives from all WHO regions.
Stakeholders were asked to score each of the 30 research topics as 1·0 (yes), 0·5 (informed but undecided answer), or 0 (no) on whether they met each of the fi ve criteria. It was possible to omit a score if a respondent did not feel confi dent to decide on a criterion; these were regarded as missing data and not part of the denominator. Summary scores for each criterion and an overall score were then computed as the sum of the scores divided by the number of actual scorers. Responses were received from all WHO regions, with a total response rate of 23% (n=271). Most (83%) responses were submitted in English, 13% in French, and 4% in Spanish. The highest proportion (24%) of those who provided demographic information came from the Western Pacifi c Region and the lowest (2·6%) from southeast Asia. Over a quarter (26%) came from the academic, research, or training institution sector of the PMNCH constituents. Of the 199 respondents who identifi ed themselves as health professionals, 168 (84%) were in roles associated with maternal and child health.
Our goal was to identify the top 10 priorities; however, two scored equally, and so the top 11 are presented in the table. The stakeholders prioritised research that would increase knowledge about ways to prevent complications and reduce unnecessary interventions, strengthen women's own capabilities, and optimise biological, social, and cultural processes. They also identifi ed the importance of examining the role of midwifery in providing quality care for all women and infants. Stakeholders also identifi ed research to improve skilled, knowledgeable, and compassionate care provided by an appropriate workforce that ensures timely referral when complications arise. The top two priorities indicate the fundamental importance of eff ective family planning services and of quality care to reduce rates of preterm birth, low birthweight, stillbirth, and perinatal mortality. Evidence indicates that midwifery care can be a key intervention to improve these outcomes, but more research is urgently needed to determine clinically and cost-eff ective models of care in diverse settings, especially in low-resource areas. 11 A focus on new measures and indicators of care components that have not traditionally been well examined will enable new benchmarks to be set for developing systems of care that meet the needs of all women and newborns.
The priorities identifi ed reveal broad knowledge domains rather than individual research questions. Research funding in the past has often targeted management of critical situations that contribute to high mortality, such as haemorrhage, hypertensive disorders, obstructed labour, preterm birth, and sepsis. 12 The priorities identifi ed in this study do not eschew the importance of complication management, but potentially restore balance by moving towards a focus on prevention. Studying ways of providing such care has the potential to improve the provision of quality care for all, enhance women's and infants' own capabilities, and maximise the health promotion potential of midwives. The Global Strategy for Women's, Children's and Adolescents' Health 2016-2030 is designed to help women, children, and adolescents survive, thrive, and transform. 13 The concepts of thriving and transforming particularly resonate with the research priorities identifi ed in this exercise. Importantly, this new knowledge could contribute to achieving Sustainable Development Goal 3, for healthy lives and wellbeing for all people. Investment in these innovative priorities has the potential to enable the rights of women and children to life and to health, and help women, infants, and families to survive and thrive. It would be transformative for families, communities, and science.
